EE583 Cost-Effectiveness of Dapagliflozin in the Treatment of Chronic Symptomatic Heart Failure With Reduced Ejection Fraction in the Netherlands

Abstract

Authors

I Kvamme G de Graaf S Nekeman S Gijsbers V Wester M Hoogendoorn

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×